Nephrocare Health Services Ltd (NEPHROPLUS) Announcements - Latest Exchange Filings with AI Summaries
Latest corporate announcements filed by Nephrocare Health Services Ltd on NSE and BSE, with an AI summary of each filing.
In Continuation to our letter dated October 21, 2026 please find enclosed link of the audio recording of the Investors'' Conference Call held on November 04, 2026 on the Unaudited Standalone ....
Audio / Video · 04 Nov 2026, 9:28 pm
Nephrocare Health Services Releases Q2FY27 Earnings Call Audio Recording Nephrocare Health Services Limited has uploaded the audio recording of its Investors' Conference Call held on 4th Nov'26 regarding the un-audited standalone and consolidated financial results for the quarter ended 30th Sep'26. The submission complies with Regulation 30 and 46(2) of the SEBI LODR Regulations, 2015, and the recording is accessible via the company's official website.
Please find attached monitoring agency report for the quarter ended September 30, 2026.
Others (Uncategorized) · 04 Nov 2026, 12:51 am
Nephrocare Health Services Releases Q2 FY27 IPO Proceeds Monitoring Report Crisil Ratings issued the Monitoring Agency Report for Nephrocare Health Services for the quarter ended 30th Sep'26. Out of total gross IPO proceeds of Rs 3,534.05 million, the company has utilized Rs 2,389.25 million, leaving Rs 1,144.80 million unutilized and parked in fixed deposits and bank accounts. Full planned debt repayment of Rs 1,359.99 million was achieved earlier. Capex deployment for new dialysis clinics reached Rs 187.39 million against a Rs 1,291.06 million allocation, facing implementation delays due to clinic finalization timelines.
Please find investor presentation for quarter and half year ended September 30, 2026.
Investor Presentation · 03 Nov 2026, 11:57 pm
NephroPlus Reports Strong H1FY27 Performance and International Expansion Nephrocare Health Services delivered strong H1FY27 results, with revenue growing 23.6% YoY to ₹585.2 crore, driven by a 12.6% YoY rise in treatments to 21.01 lakh and a 9.7% YoY increase in revenue per treatment to ₹2,785. Adjusted EBITDA rose 15.3% YoY to ₹134.4 crore (23.0% margin), while adjusted PAT surged 34.7% YoY to ₹76.1 crore. The global clinic network expanded to 570 centres across six countries, with international operations contributing 47% of Q2FY27 revenue following entries into Kazakhstan and Saudi Arabia alongside Philippines expansion.
Press release on Unaudited standalone and consolidated financial results for quarter and half year ended September 30, 2026.
Press Release · 03 Nov 2026, 11:48 pm
NephroPlus Delivers Strong H1FY27 Performance Driven by International Expansion and Volume Growth NephroPlus reported a 23.6% YoY rise in consolidated H1FY27 revenue to ₹585.2 crore, exceeding guidance, driven by a 12.6% YoY growth in treatments to 21.01 lakh and a 9.7% YoY increase in revenue per treatment to ₹2,785. Adjusted EBITDA rose 15.3% YoY to ₹134.4 crore, while Adjusted PAT surged 34.7% YoY to ₹76.1 crore with margins expanding 107 bps to 13.0%. For Q2FY27, revenue reached ₹303.4 crore, up 23.5% YoY. The network expanded to 570 clinics across six countries, with international markets contributing ~47% of revenue.
Outcome of the Board meeting held on November 3, 2026 for considering and approving the financial results for the period ended September 30, 2026.
Outcome · 03 Nov 2026, 11:42 pm
Nephrocare Health Services Limited has submitted to the Exchange, the financial results for the period ended September 30, 2026.
Outcome · 03 Nov 2026, 11:30 pm
Nephrocare Health Services Ltd - Financial Result for the Quarter ended 30th Sep'26 (Consolidated, INR Million) ■ Revenue: 3,034 (+23.5% YoY | +7.7% QoQ) ■ EBITDA: 671 (+5.0% YoY | +5.1% QoQ) ■ EBITDA Margin (%): 22.1 (-389 bps YoY | -55 bps QoQ) ■ PAT: 335 (Loss to Profit YoY | +4.9% QoQ) ■ EPS (INR): 3.25 (Loss to Profit YoY | +4.5% QoQ)
Pursuant to Reg 30 of SEBI Listing Regulations, we wish to hereby inform that the tax assessment order against the Company''s overseas wholly-owned subsidiary has been declared invalid ....
Others (Uncategorized) · 03 Nov 2026, 3:48 am
Nephrocare Wins Relief as Uzbekistan Court Invalidates ₹14.79 Crore Tax Demand The Tashkent Inter-District Administrative Court in Uzbekistan ruled in favor of Nephrocare Health Services Limited's wholly-owned subsidiary, Nephrocare Health Services Central Asia LLC, declaring a ₹14.79 crore (UZS 18.27 billion) tax and penalty demand invalid. The assessment, covering Jan'23 to Dec'25, was quashed due to procedural irregularities. The court directed the Tashkent City Tax Department to reconsider the audit within 30 days of the order entering into force, stipulating that any reassessment cannot worsen the subsidiary's financial position relative to the invalidated decision.
Pursuant to Reg 30 of SEBI Listing Regulations, we hereby inform you that Nephrocare Health Services, Philippines Inc., a step-down wholly owned subsidiary of the company has acquired a ....
Others (Uncategorized) · 28 Oct 2026, 1:12 am
Nephrocare Health Services Expands in Philippines via Dialysis Center Asset Acquisition Nephrocare Health Care Services, Philippines Inc., a step-down wholly-owned subsidiary of Nephrocare Health Services Limited, entered into an Asset Transfer Agreement on 27th Oct'26 with JCM Summit Health Inc. The agreement entails the acquisition of dialysis center assets located in Quezon City, Philippines. The transaction value exceeds the company's internal materiality threshold, though specific financial consideration remains undisclosed due to commercial sensitivity. The non-related party transaction grants no special governance or board rights.
Pursuant to Reg 30 of the SEBI Listing Regulations, we hereby inform you that the Company has scheduled an investor conference call as per the disclosure annexed herewith.
Intimation · 04 Nov 2026, 11:00 am
Nephrocare Health Services Schedules Q2FY27 Earnings Conference Call Nephrocare Health Services Limited will host its Q2FY27 earnings conference call on 4th Nov'26 at 11:00 AM IST, organized by IIFL Capital Services. Management will discuss the un-audited standalone and consolidated financial results for the quarter and half-year ended 30th Sep'26, alongside business strategy and outlook. Key participants include Chairman & Managing Director Vikram Vuppala, Co-Founder Kamal Shah, Group CEO Rohit Singh, and Group CFO Prashant Goenka. No unpublished price-sensitive information will be shared.
To consider and approve the financial results for the period ended September 30, 2026
Intimation · 03 Nov 2026, 5:30 am
NEPHROCARE HEALTH SERVICES LIMITED has informed the Exchange about Board Meeting to be held on 03-Nov-2026 to inter-alia consider and approve the Unaudited Financial results of the Company for the Half Yearly ended September 2026 .
Intimation · 03 Nov 2026, 5:30 am
Nephrocare Health Services Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 03/11/2026 ,inter alia, to consider and approve the Unaudited Standalone ....
Intimation · 03 Nov 2026, 5:30 am
Nephrocare Health Services Schedules Board Meeting for Q2 FY27 Financial Results Nephrocare Health Services Limited has scheduled a Board of Directors meeting on 3rd Nov'26 to consider and approve the un-audited standalone and consolidated financial results for the quarter and half-year ended 30th Sep'26. Consequently, the trading window for dealing in company securities remains closed for all designated persons and their immediate relatives from 1st Oct'26 until 5th Nov'26 (both days inclusive).
The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Polar Capital Funds PLC
Acquisition/ Disposal of Shares · 28 Sept 2026, 7:36 pm
Pursuant to Reg 30 of the SEBI Listing Regulations, we hereby inform you that the Company has scheduled an investor conference call as per the disclosure annexed herewith.
Intimation · 22 Sept 2026, 10:13 pm
Nephrocare Health Services to Attend PL Capital Investor Conference Nephrocare Health Services Limited will attend the PL Capital Investor Conference on 29th Sep'26 at Trident BKC, Mumbai, starting at 1:00 PM IST. Company officials are scheduled to participate in 1*1 and group meetings. All interactions will focus on publicly available information, with no unpublished price-sensitive information (UPSI) being discussed.
Pursuant to Reg 30 of SEBI Listing Regulations, we hereby inform the update on Credit Ratings of the Company received from India Ratings and Research Private Limited as per the disclosure ....
Others (Uncategorized) · 19 Sept 2026, 2:29 am
India Ratings Upgrades Nephrocare Health Services to 'IND AA-'; Outlook Stable India Ratings upgraded Nephrocare Health Services Limited’s long-term bank facilities rating to ‘IND AA-’ from ‘IND A+’ with a Stable outlook, while reaffirming the short-term rating at ‘IND A1+’ on 18th Sep'26. The upgrade reflects NHSL's market leadership with over 50% share in organized Indian dialysis, solid international expansion contributing 42% of FY26 revenues, and healthy EBITDA margins of 22.7% (INR2.3 billion). Following a Dec'25 equity raise, NHSL achieved a net cash balance sheet with INR4.3 billion in cash against INR0.8 billion debt at FYE26.
Disclosure under Reg 30 of SEBI Listing Regulations -Rationalisation and Consolidation of Company''s Step-down Subsidiaries in the Philippines as per the disclosure annexed herewith.
Others (Uncategorized) · 18 Sept 2026, 9:49 pm
Nephroplus Board Approves Consolidation of Step-Down Subsidiaries in the Philippines On 18th Sep'26, Nephrocare Health Services Limited's board approved the phased rationalisation and consolidation of its Philippine step-down subsidiaries under Nephrocare Health Care Services Philippines, Inc. The internal reorganisation aims to simplify group entity structure, streamline administrative and compliance processes, optimise costs, and enhance operational efficiencies. Accounted for as a common-control transaction, the restructuring involves no third-party investors, preserves the company’s shareholding pattern, and causes no change in its ultimate economic interest or control over Philippine operations, pending necessary regulatory approvals in India and the Philippines.
Pursuant to Reg 30 of SEBI Listing Regulations, we hereby inform you that Nephrocare Health Services, Philippines Inc., a step-down wholly owned subsidiary of the Company has acquired a ....
Others (Uncategorized) · 15 Sept 2026, 12:03 am
Nephrocare Health Services Expands in Philippines via INR 10.25 Crore Dialysis Center Acquisition Nephrocare Health Services Limited announced that its overseas step-down wholly-owned subsidiary, Nephrocare Health Care Services, Philippines Inc., entered into an Asset Transfer Agreement on 14th Sep'26 with Renal One Dialysis Corp. The subsidiary will acquire dialysis center assets located in Plaridel, Bulacan, Philippines, for a total consideration of PhP 67.20 million (approximately INR 10.25 crore at an exchange rate of 1 PHP = INR 1.5248). The arm's length transaction does not involve related parties or grant special rights.
We hereby inform that the Company has approved grant of ESOPs under the Scheme as per the disclosure annexed herewith.
Others (Uncategorized) · 03 Sept 2026, 4:58 pm
Pursuant to Reg 30 of SEBI Listing Regulations, we wish to hereby inform that NephroPlus Health Services Kazakhstan LLP, an overseas subsidiary of the Company has entered into a Share Purchase ....
Others (Uncategorized) · 02 Sept 2026, 5:15 am
Pursuant to Regulation 30 of SEBI Listing Regulations, we hereby inform that the Company has received Tax demand pursuant to Tax Audit as per the annexed disclosure.
Others (Uncategorized) · 01 Sept 2026, 12:41 am
Nephroplus Subsidiary in Uzbekistan Receives ₹14.79 Crore Tax Demand Nephroplus' wholly-owned Uzbekistan subsidiary, NCA, received a tax order on 24 Aug'26 for the period Jan'23-Dec'25. The Tashkent Tax Department has imposed a net additional tax of ~₹11.50 crore and a penalty of ~₹3.29 crore, totaling ~₹14.79 crore. The dispute arises from a revenue data discrepancy affecting NCA's eligibility for tax exemptions on dialysis services. Nephroplus believes the assessment is incorrect, expects it to be quashed, and is evaluating legal remedies, stating no material adverse impact is anticipated.
Please find enclosed herewith Transcripts for the investors Earning call held on August 12, 2026.
Transcript · 19 Aug 2026, 10:33 pm
Pursuant to Reg 30 of SEBI Listing Regulations, we hereby inform that Nephrocare Health Services, Phillipines Inc., a step-down wholly-owned subsidiary of the Company has acquired a dialysis ....
Others (Uncategorized) · 17 Aug 2026, 7:18 pm
Nephroplus Subsidiary Acquires Dialysis Center in the Philippines Nephrocare Health Services' step-down subsidiary in the Philippines has acquired a dialysis center's assets from Assumption Dialysis Center. The Asset Transfer Agreement was executed on 17 Aug '26 for a total consideration of PhP 75 million. This acquisition, located in Abuyog, Leyte, Philippines, expands the company's overseas footprint. The seller is not a related party to Nephroplus or its promoters, and the transaction is not classified as a related-party transaction. This strategic purchase aligns with the company's international growth plans.
Declartion of voting results along with scrutinizers report of the 17th AGM of the Company.
Annual General Meeting · 14 Aug 2026, 12:42 am
Pursuant to Reg 30 of the SEBI Listing Regulations, we hereby inform you that the Company has scheduled an investor conference call as per the disclosure annexed herewith.
Intimation · 13 Aug 2026, 4:56 pm
Nephroplus Schedules Investor Meetings at MOSL Conference Nephrocare Health Services (NEPHROPLUS) has scheduled group and one-on-one investor meetings at the MOSL Conference. The event will take place on 18th Aug'26 from 11:00 AM IST onwards at the Grand Hyatt in Mumbai. Company officials will attend, and discussions will be limited to publicly available information, with no unpublished price-sensitive information (UPSI) to be shared. The schedule is subject to potential changes.
Pursuant to Reg 30 of SEBI Listing Regulations, we hereby inform that Nephrocare Health Services, Phillipines Inc., an overseas stepdown wholly-owned subsidiary of the Company has acquired ....
Others (Uncategorized) · 13 Aug 2026, 4:51 pm
Nephroplus Subsidiary Acquires Dialysis Center in the Philippines Nephroplus's step-down subsidiary in the Philippines has acquired assets of a dialysis center in Davao City. The Asset Transfer Agreement with Juan Nephro Dialysis Center was signed on 12 Aug'26 for a total consideration of PHP 71.8 million. This acquisition expands the company's international footprint. The seller is not a related party, and the transaction is not a related party transaction. The deal involves no special rights or share issuance, representing a straightforward asset purchase to grow operations in the Philippines.